HOWARD J. SCHWARTZ, M.D.; FRANCIS C. LOWELL, M.D., F.A.C.P.; JAMES C. MELBY, M.D.
This content is PDF only. Please click on the PDF icon to access.
The eosinopenic response to 40 mg of cortisol given intravenously was studied in 19 unselected asthmatics (group A) and in 6 asthmatics who exhibit clinical resistance to cortisol's antiasthma effect (group B). The changes in total eosinophil counts were -35%, -77%, and -73% in group A; and -10%, -36%, and 3.6% in group B at 2, 4, and 6 hr after administration.
Cortisol turnover studies in four subjects from each group were done using a tracer dose of tritium-labeled cortisol immediately followed by 40 mg of unlabeled cortisol intravenously. Plasma levels were measured at 30, 60, 90, and 120 min; 6-hr urine collections were made. Cortisol half-life values in group A were 123, 133, 120, and 132 min; in group B they were 81, 96, 75, and 90 min.
Thus, asthma requiring unusually large doses of steroid for control may be associated with a decreased eosinopenic response to cortisol and an accelerated plasma cortisol clearance.
SCHWARTZ HJ, LOWELL FC, MELBY JC. Steroid Resistance in Bronchial Asthma. Ann Intern Med. 1968;69:493–499. doi: https://doi.org/10.7326/0003-4819-69-3-493
Download citation file:
Published: Ann Intern Med. 1968;69(3):493-499.
Asthma, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use